Onyx Pharma Gets Japanese Drug Development Deal

Onyx Pharmaceuticals Inc. said Wednesday it could receive more than $300 million through an agreement with Ono Pharmaceutical Co. Ltd. to develop and sell two potential cancer treatments in Japan.
Star Tribune